GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (OSTO:INTEG B) » Definitions » YoY EBITDA Growth

Integrum AB (OSTO:INTEG B) YoY EBITDA Growth : -381.33% (As of Apr. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Integrum AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Integrum AB's YoY EBITDA Growth for the quarter that ended in Apr. 2025 was -381.33%.

Integrum AB's EBITDA per Share for the three months ended in Apr. 2025 was kr-0.47.

Integrum AB YoY EBITDA Growth Historical Data

The historical data trend for Integrum AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrum AB YoY EBITDA Growth Chart

Integrum AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.69 372.00 -916.91 140.86 -466.52

Integrum AB Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 135.02 -287.88 -231.32 -632.08 -381.33

Integrum AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Integrum AB's YoY EBITDA Growth for the fiscal year that ended in Apr. 2025 is calculated as:

YoY EBITDA Growth (A: Apr. 2025 )
=(EBITDA per Share (A: Apr. 2025 )-EBITDA per Share (A: Apr. 2024 ))/ | EBITDA per Share (A: Apr. 2024 ) |
=(-1.664-0.454)/ | 0.454 |
=-466.52 %

Integrum AB's YoY EBITDA Growth for the quarter that ended in Apr. 2025 is calculated as:

YoY EBITDA Growth (Q: Apr. 2025 )
=(EBITDA per Share (Q: Apr. 2025 )-EBITDA per Share (Q: Apr. 2024 )) / | EBITDA per Share (Q: Apr. 2024 )) |
=(-0.467-0.166)/ | 0.166 |
=-381.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrum AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Integrum AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrum AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (OSTO:INTEG B) » Definitions » YoY EBITDA Growth
Comparable Companies
OSTO:BRAIN OSTO:ACARIX OSTO:QLINEA OSTO:BOUL OSTO:MNTC OSTO:PRO OSTO:NEOLA OSTO:DIGN OSTO:SEZI XSAT:BIBB ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE XAMS:PHIA
Traded in Other Exchanges
6Y1:Germany
Address
Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Website
http://www.integrum.se
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.

Integrum AB Headlines

No Headlines